Ventyx Biosciences, Inc. (VTYX) Insider Ownership

Historic Insider Ownership Trends

As of March 23, 2026, Ventyx Biosciences's top three insider holders are Investments I, L.P. Nsv (TenPercentOwner, 16.89Mn shares), Partners Iii Lp Nsv (TenPercentOwner, 8.56Mn shares), Partners Iii Lp Nsv (TenPercentOwner, 7.10Mn shares).

Ventyx Biosciences's equity is distributed as 0.00% to institutions, 57.59% to company executives, and 42.41% to other and public holders.
According to Business Quant data, insider ownership at Ventyx Biosciences stands at 57.59%, comprising 41.06Mn shares out of 71.30Mn total outstanding.
Their holdings in Ventyx Biosciences increased 0.24%, from 40.96Mn shares to 41.06Mn shares over the prior quarter.
There were no significant purchases by Ventyx Biosciences's insiders in the last 90 days.
On the selling side, Raju Mohan (Ceo And President) led at Ventyx Biosciences with 5.19Mn shares sold during the same 90-day period ending March 23, 2026.

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.

Holder	Position	Shares (Direct)	Shares (Indirect)	Report Date
Investments I, L.P. Nsv		0	16,892,528	25 Oct, 2021
Partners Iii Lp Nsv		8,556,866	0	13 Jul, 2023
Partners Iii Lp Nsv		0	7,102,969	26 Jun, 2024
Aaron Royston		0	3,997,269	25 Oct, 2021
Asset Management, Lp Cormorant		0	1,410,303	27 Oct, 2021
William J. Sandborn	See Remarks	48,389	0	01 Sep, 2023
Martin Auster	Chief Financial Officer	24,303	0	03 Apr, 2024
William J. Sandborn	See Remarks	0	24,194	08 Aug, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.

Rows:

Download Data

Transaction Date	Insider Name	Security Class	Transaction Type	Shares Traded	Price	Ownership	Code
04 Mar, 2026	Raju Mohan	Common Stock	D	2,372,863	-	D	D
04 Mar, 2026	William Richard White	Stock Option (Right to Buy)	D	33,000	-	D	D
04 Mar, 2026	Mark S Forman	Common Stock	D	6,000	-	D	D
04 Mar, 2026	Allison Hulme	Stock Option (Right to Buy)	D	33,000	-	D	D
04 Mar, 2026	Matthew Richard Moore	Stock Option (Right to Buy)	D	145,000	-	D	D
04 Mar, 2026	Roy Gonzales	Common Stock	D	5,313	-	D	D
04 Mar, 2026	John Nuss	Common Stock	D	489,481	-	D	D
04 Mar, 2026	Sheila Gujrathi	Common Stock	D	130,000	-	I	D
04 Mar, 2026	Onaiza Cadoret-Manier	Stock Option (Right to Buy)	D	33,000	-	D	D
04 Mar, 2026	Roy Gonzales	Stock Option (Right to Buy)	D	109,200	-	D	D
04 Mar, 2026	John Nuss	Restricted Stock Units	D	9,063	-	D	D
04 Mar, 2026	Mark S Forman	Stock Option (Right to Buy)	D	85,000	-	D	D
04 Mar, 2026	Onaiza Cadoret-Manier	Stock Option (Right to Buy)	D	40,000	-	D	D
04 Mar, 2026	Allison Hulme	Stock Option (Right to Buy)	D	40,000	-	D	D
04 Mar, 2026	Raju Mohan	Restricted Stock Units	D	23,688	-	D	D
04 Mar, 2026	Sheila Gujrathi	Stock Option (Right to Buy)	D	33,000	-	D	D
04 Mar, 2026	William Richard White	Stock Option (Right to Buy)	D	40,000	-	D	D
04 Mar, 2026	Matthew Richard Moore	Stock Option (Right to Buy)	D	320,000	-	D	D
04 Mar, 2026	John Nuss	Stock Option (right to buy)	D	415,104	-	D	D
04 Mar, 2026	Roy Gonzales	Stock Option (Right to Buy)	D	17,500	-	D	D

Showing 1 to 20 of 357 transactions

Research Tools

Ventyx Biosciences, Inc. (VTYX) Insider Ownership

Historic Insider Ownership Trends

Top Direct Holders

Recent Insider Transactions

Create an account

Sign In

Reset Password